Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

350 ARTÍCULOS , VIENDO DEL 31 AL 45

Ultrasound and Electromyography Guidance for Injection of the Longus Colli With Botulinum Toxin for the Treatment of Cervical Dystonia

Allison SK, Odderson IR.

Ultrasound Q. 2016 Sep;32(3):302-6. doi: 10.1097/RUQ.0000000000000226.

Olanzapine-related repetitive focal seizures with lingual dystonia

Anzellotti F, Capasso M, Frazzini V, Onofrj M.

Epileptic Disord. 2016 Mar;18(1):83-6. doi: 10.1684/epd.2016.0805.

Genetics of movement disorders in the next-generation sequencing era

Olgiati S, Quadri M, Bonifati V.

Mov Disord. 2016 Apr;31(4):458-70. doi: 10.1002/mds.26521. Epub 2016 Feb 22.

A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia

Han Y, Stevens AL, Dashtipour K, Hauser RA, Mari Z.

J Neurol. 2016 Apr;263(4):772-80. doi: 10.1007/s00415-016-8050-2. Epub 2016 Feb 25.

Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe?

Fraint A, Vittal P, Comella C.

Ther Clin Risk Manag. 2016 Feb 5;12:147-54. doi: 10.2147/TCRM.S99239. eCollection 2016.

A clinical trial of safety and tolerability for the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease

Khasnavis T, Reiner G, Sommerfeld B, Nyhan WL, Chipkin R, Jinnah HA.

Mol Genet Metab. 2016 Apr;117(4):401-6. doi: 10.1016/j.ymgme.2016.02.005. Epub 2016 Feb 18.

Bilateral Lower Sternocleidomastoid Botulinum Toxin Injections to Address Refractory Anterocollis

Peng-Chen Z, Thompson A, Rodriguez RL.

Neurologist. 2016 Mar;21(2):30-1. doi: 10.1097/NRL.0000000000000072.

Novel mutation in SUCLA2 identified on sequencing analysis

Güngör O, Özkaya AK, Güngör G, Karaer K, Dilber C, Aydin K.

Pediatr Int. 2016 Jul;58(7):659-61. doi: 10.1111/ped.12921. Epub 2016 Mar 8.

Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?

Wichmann T, DeLong MR.

Neurotherapeutics. 2016 Apr;13(2):264-83. doi: 10.1007/s13311-016-0426-6.

Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical Practice

Scaglione F.

Toxins (Basel). 2016 Mar 4;8(3):65. doi: 10.3390/toxins8030065.

Multifocal Motor Neuropathy Presenting as Pseudodystonia

Garg N, Heard RNS, Kiers L, Gerraty R, Yiannikas C.

Mov Disord Clin Pract. 2016 Mar 11;4(1):100-104. doi: 10.1002/mdc3.12336. eCollection 2017 Jan-Feb.

Programming Deep Brain Stimulation for Tremor and Dystonia: The Toronto Western Hospital Algorithms

Picillo M, Lozano AM, Kou N, Munhoz RP, Fasano A.

Brain Stimul. 2016 May-Jun;9(3):438-452. doi: 10.1016/j.brs.2016.02.003. Epub 2016 Feb 12.

Deep brain stimulation for intractable tardive dystonia: Literature overview

Sobstyl M, Ząbek M.

Neurol Neurochir Pol. 2016;50(2):114-22. doi: 10.1016/j.pjnns.2016.01.004. Epub 2016 Jan 16.

British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin

Marion MH, Humberstone M, Grunewald R, Wimalaratna S.

Pract Neurol. 2016 Aug;16(4):288-95. doi: 10.1136/practneurol-2015-001335. Epub 2016 Mar 14.

Deep brain stimulation for dystonia: review of the literature

Mehdorn HM.

J Neurosurg Sci. 2016 Jun;60(2):199-210. Epub 2016 Mar 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias